scholarly journals Scaling waist girth for differences in body size reveals a new improved index associated with cardiometabolic risk

2016 ◽  
Vol 27 (11) ◽  
pp. 1470-1476 ◽  
Author(s):  
A. M. Nevill ◽  
M. J. Duncan ◽  
I. M. Lahart ◽  
G. R. Sandercock

2010 ◽  
Vol 2010 ◽  
pp. 1-7 ◽  
Author(s):  
U. Risérus ◽  
U. de Faire ◽  
L. Berglund ◽  
M.-L. Hellénius

Background. Waist girth and BMI are commonly used as markers of cardiometabolic risk. Accumulating data however suggest that sagittal abdominal diameter (SAD) or “abdominal height” may be a better marker of intra-abdominal adiposity and cardiometabolic risk. We aimed to identify cutoffs for SAD using a cardiometabolic risk score.Design. A population-based cross-sectional study.Methods. In 4032 subjects (1936 men and 2096 women) at age 60, different anthropometric variables (SAD, BMI, waist girth, and waist-to-hip ratio) were measured and cardiometabolic risk score calculated. ROC curves were used to assess cutoffs.Results. Among men SAD showed the strongest correlations to the majority of the individual risk factors; whereas in women SAD was equal to that of waist girth. In the whole sample, the area under the ROC curve was highest for SAD. The optimal SAD cutoff for an elevated cardiometabolic risk score in men was∼22 cm (95%CI; 21.6 to 22.8) and in women∼20 cm (95%CI; 19.4 to 20.8). These cutoffs were similar if the Framingham risk score was used.Conclusions. These cutoffs may be used in research and screening to identify “metabolically obese” men who would benefit from lifestyle and pharmacological interventions. These results need to be verified in younger age groups.



PLoS ONE ◽  
2012 ◽  
Vol 7 (9) ◽  
pp. e45755 ◽  
Author(s):  
Lynne M. Boddy ◽  
Non E. Thomas ◽  
Stuart J. Fairclough ◽  
Keith Tolfrey ◽  
Sinead Brophy ◽  
...  


2016 ◽  
Vol 27 (2) ◽  
pp. 48-54 ◽  
Author(s):  
Antonios Stavropoulos-Kalinoglou ◽  
George S Metsios ◽  
Yiannis Koutedakis ◽  
George D Kitas


2017 ◽  
Vol 42 (3) ◽  
pp. 424-432 ◽  
Author(s):  
J de la Cuesta-Zuluaga ◽  
V Corrales-Agudelo ◽  
J A Carmona ◽  
J M Abad ◽  
J S Escobar


Maturitas ◽  
2016 ◽  
Vol 92 ◽  
pp. 162-167 ◽  
Author(s):  
E. Gregorio-Arenas ◽  
P. Ruiz-Cabello ◽  
D. Camiletti-Moirón ◽  
N. Moratalla-Cecilia ◽  
P. Aranda ◽  
...  


Author(s):  
Tiago Rodrigues de Lima ◽  
Xuemei Sui ◽  
Diego Augusto Santos Silva

Muscle strength (MS) has been associated with cardiometabolic risk factors (CMR) in adolescents, however, the impact attributed to body size in determining muscle strength or whether body size acts as a confounder in this relationship remains controversial. We investigated the association between absolute MS and MS normalized for body size with CMR in adolescents. This was a cross-sectional study comprising 351 adolescents (44.4% male; 16.6 ± 1.0 years) from Brazil. MS was assessed by handgrip and normalized for body weight, body mass index (BMI), height, and fat mass. CMR included obesity, high blood pressure, dyslipidemia, glucose imbalance, and high inflammation marker. When normalized for body weight, BMI, and fat mass, MS was inversely associated with the presence of two or more CMR among females. Absolute MS and MS normalized for height was directly associated with the presence of two or more CMR among males. This study suggests that MS normalized for body weight, BMI, and fat mass can be superior to absolute MS and MS normalized for height in representing lower CMR among females. Absolute MS and MS normalized for height were related to higher CMR among males.



2016 ◽  
Vol 22 ◽  
pp. 125
Author(s):  
Reem Alshenaifi ◽  
Eman Alfadhli ◽  
Hanan Habeeb ◽  
Alaa Sondokji ◽  
Mohammed Makkawi ◽  
...  


Author(s):  
Sanem Kayhan ◽  
Nazli Gulsoy Kirnap ◽  
Mercan Tastemur

Abstract. Vitamin B12 deficiency may have indirect cardiovascular effects in addition to hematological and neuropsychiatric symptoms. It was shown that the monocyte count-to-high density lipoprotein cholesterol (HDL-C) ratio (MHR) is a novel cardiovascular marker. In this study, the aim was to evaluate whether MHR was high in patients with vitamin B12 deficiency and its relationship with cardiometabolic risk factors. The study included 128 patients diagnosed with vitamin B12 deficiency and 93 healthy controls. Patients with vitamin B12 deficiency had significantly higher systolic blood pressure (SBP), diastolic blood pressure (DBP), MHR, C-reactive protein (CRP) and uric acid levels compared with the controls (median 139 vs 115 mmHg, p < 0.001; 80 vs 70 mmHg, p < 0.001; 14.2 vs 9.5, p < 0.001; 10.2 vs 4 mg/dl p < 0.001; 6.68 vs 4.8 mg/dl, p < 0.001 respectively). The prevalence of left ventricular hypertrophy was higher in vitamin B12 deficiency group (43.8%) than the control group (8.6%) (p < 0.001). In vitamin B12 deficiency group, a positive correlation was detected between MHR and SBP, CRP and uric acid (p < 0.001 r:0.34, p < 0.001 r:0.30, p < 0.001 r:0.5, respectively) and a significant negative correlation was detected between MHR and T-CHOL, LDL, HDL and B12 (p < 0.001 r: −0.39, p < 0.001 r: −0.34, p < 0.001 r: −0.57, p < 0.04 r: −0.17, respectively). MHR was high in vitamin B12 deficiency group, and correlated with the cardiometabolic risk factors in this group, which were SBP, CRP, uric acid and HDL. In conclusion, MRH, which can be easily calculated in clinical practice, can be a useful marker to assess cardiovascular risk in patients with vitamin B12 deficiency.





Sign in / Sign up

Export Citation Format

Share Document